.BETA.-CYCLODEXTRIN, 6A,6B,6C,6D,6E,6F,6G-HEPTAKIS-S-(2-CARBOXYETHYL)-6A,6B,6C,6D,6E,6F,6G-HEPTATHIO-, HEPTASODIUM SALT
UNII KK6MFE7949

Substance Identification & Data

This profile provides standardized clinical and technical data for .beta.-cyclodextrin, 6a,6b,6c,6d,6e,6f,6g-heptakis-s-(2-carboxyethyl)-6a,6b,6c,6d,6e,6f,6g-heptathio-, Heptasodium Salt, uniquely identified by the FDA Unique Ingredient Identifier (UNII) KK6MFE7949.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 426267-22-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

KK6MFE7949

CAS Registry Number

426267-22-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

.BETA.-CYCLODEXTRIN, 6A,6B,6C,6D,6E,6F,6G-HEPTAKIS-S-(2-CARBOXYETHYL)-6A,6B,6C,6D,6E,6F,6G-HEPTATHIO-, HEPTASODIUM SALT

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C63H91O42S7.7Na

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

RYWNKQGLGLMGSB-LUTSSWHUSA-G

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

11051553

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C(SCCC([O-])=O)[C@@H]1[C@]2(O[C@]3(O[C@H](CSCCC([O-])=O)[C@]([C@H](O)[C@H]3O)(O[C@]4(O[C@H](CSCCC([O-])=O)[C@]([C@H](O)[C@H]4O)(O[C@]5(O[C@H](CSCCC([O-])=O)[C@]([C@H](O)[C@H]5O)(O[C@]6(O[C@H](CSCCC([O-])=O)[C@@](O[C@]7(O[C@H](CSCCC([O-])=O)[C@@](O[C@]8(O[C@H](CSCCC([O-])=O)[C@@](O[C@@](O1)([C@H](O)[C@H]2O)[H])([C@H](O)[C@H]8O)[H])[H])([C@H](O)[C@H]7O)[H])[H])([C@H](O)[C@H]6O)[H])[H])[H])[H])[H])[H])[H])[H])[H].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for .beta.-cyclodextrin, 6a,6b,6c,6d,6e,6f,6g-heptakis-s-(2-carboxyethyl)-6a,6b,6c,6d,6e,6f,6g-heptathio-, Heptasodium Salt. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

.BETA.-CYCLODEXTRIN, 6A,6B,6C,6D,6E,6F,6G-HEPTAKIS-S-(2-CARBOXYETHYL)-6A,6B,6C,6D,6E,6F,6G-HEPTATHIO-, HEPTASODIUM SALT

.BETA.-CYCLODEXTRIN, 6A,6B,6C,6D,6E,6F,6G-HEPTAKIS-S-(2-CARBOXYETHYL)-6A,6B,6C,6D,6E,6F,6G-HEPTATHIO-, SODIUM SALT (1:7)

Systematic Nomenclature

HEPTASODIUM;3-(((1S,3S,5S,6S,8S,10S,11S,13S,15S,16S,18S,20S,21S,23S,25S,26S,28S,30S,31S,33S,35S,36R,37R,38R,39R,40R,41R,42R,43R,44R,45R,46R,47R,48R,49R)-10,15,20,25,30,35-HEXAKIS(2-CARBOXYLATOETHYLSULFANYLMETHYL)-36,37,38,39,40,41,42,43,44,45,46,47,48,49-TETRADECAHYDROXY-2,4,7,9,12,14,17,19,22,24,27,29,32,34-TETRADECAOXAOCTACYCLO(31.2.2.23,6.28,11.213,16.218,21.223,26.228,31)NONATETRACONTAN-5-YL)METHYLSULFANYL)PROPANOATE

SYS